Navigation Links
Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient
Date:1/11/2008

$110,000,000.00 lawsuit filed 11 Dec. 2008

ATLANTA, Jan. 11 /PRNewswire-USNewswire/ -- Cryolife, Inc., (NYSE: CRY) the country's largest distributor of cadaver tissue has once again severely maimed an elective knee surgery patient, Michael Hohenbery, with a contaminated infected knee tissue implant. Shockingly the same deadly organism that devastated Mr. Hohenbery took the life of young Brian Lykins of Minnesota in 2001.

The Lykins' death, another of the Keenan Law Firm's clients, first alerted the nation of the unregulated cadaver tissue billion dollar industry. Brian's death led the FDA shutdown in 2002 of Cryolife's tissue business and the passage of 900 plus pages of safety regulations which at the time of passage were insufficient and created large loopholes.

The FDA eventually after a year in mid 2003 permitted Cryolife to resume distribution of cadaver tissue but yet less than 30 days later a teenager from Denver was catastrophically infected by diseased knee cadaver tissue. Over the years many lawsuits have been prosecuted across the United Stated, Europe, and other countries concerning unsafe cadaver processing practices.

The recent victim Michael Hohenbery a farm equipment mechanic from downstate Illinois can no longer work and will be on mega antibiotics and pain medications the rest of his life. His suit will be filed Friday in Cobb County the location of Cryolife.

The Hohenbery case once again proves the unsafe and dangerous practices of Cryolife and the ineffectiveness of the safety regulations. While all states require licensure, testing and health certificates for barbers, nail salon technicians, and masseuses, there are no regulations regarding the qualifications of anyone handling and processing cadaver tissue.

"With over one million operations a year using cadaver tissues, how many more people will die or be seriously injured from dangerous unsafe practices of Cryolife. This travesty must stop," said Don Keenan attorney for Michael Hohenbery.

Don Keenan is available for comment 24/7.


'/>"/>
SOURCE KEENAN LAW FIRM/KEENAN'S KIDS FOUNDATION
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife Names Philip Theodore as Vice President, General Counsel
2. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
5. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
6. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
7. CryoLife to Present at OneMedPlace Finance Forum
8. CryoLife Announces Record Preservation Services and Product Revenues for 2007
9. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
10. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
Breaking Biology Technology:
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):